- Obama not worried about Ebola at upcoming African summit in D.C.
- Obama: ‘We tortured some folks’ after 9/11
- Obama administration asked whole D.C. Circuit to take on major Obamacare case
- Mark Levin: Topple GOP leadership or country will ‘unravel’
- Massachusetts to let police chief deny gun buys to those deemed unfit
- John Kerry condemns attack on Israeli soldiers, kidnapping
- U.S. starts to evacuate American Ebola patients from West Africa: Report
- Geraldo slammed as ‘dummy’ for backing Clinton’s bin Laden claim
- Israeli spokesman: No need to debate who broke the cease-fire
- 35 Palestinians killed; Israeli officer missing
FDA labs to remain open until review
Question of the Day
The Food and Drug Administration has suspended its plan to cut half its laboratories until a new Cabinet-level panel finishes its review of ways to ensure the safety of imports, FDA Commissioner Andrew C. von Eschenbach said yesterday.
The suspension will allow officials to “step back, analyze and assess” the results of the high-level review, Dr. von Eschenbach told reporters.
The FDA has been under increasing fire as concerns rise over tainted food and drug imports from China and elsewhere.
President Bush last month set up a panel to examine import safety, headed by Health and Human Services Secretary Michael O. Leavitt, that will report back to Mr. Bush next month.
Mr. Dingell, chairman of the House Energy and Commerce Committee, and Mr. Stupak, who heads the panel’s oversight and investigations subcommittee, are concerned about what they call a plan to “drastically cut” FDA laboratory analysts.
Dr. von Eschenbach said the panel’s review could lead to increased cooperation with Customs and Border Protection, the Agriculture Department and state authorities.
Margaret Glavin, associate commissioner for regulatory affairs, said in a memo yesterday that the FDA had “decided to take another look at our proposed design” and that the suspension would allow the FDA to consider its structure in light of recommendations from the panel and other factors, such as congressional sentiments.
Dr. von Eschenbach stressed that the reorganization is not aimed at cutting costs but would be an effort to create a “modern infrastructure that would be more efficient and more effective and better equipped.”
Mr. Stupak dismissed the suspension yesterday, saying, “Not once, in the 70,000 pages of documents that our subcommittee received from the FDA, does the FDA justify why this reorganization plan makes sense from either a safety or a cost standpoint.
“Whether they are closed today or 90 days from now, closing the FDA“s field labs, and consolidating the district offices, which places more power in Washington, makes no sense for America”s food safety.”
By Orrin G. Hatch
Procedural changes impede the chamber's traditional deliberative function
- U.N. condemns Israel, U.S. for not sharing Iron Dome with Hamas
- Border agents cleared of civil rights complaints from illegal immigrant children
- Porn-surfing feds blame boredom, lack of work for misbehavior
- Obama military strategy too weak for future security, panel reports
- 'Big Bang' star Mayim Bialik helps send bulletproof vests to IDF
- Ben Carson takes major step toward presidential campaign
- Pentagon wants extra $19M to equip, train Ukrainian troops
- Ted Nugent slams 'lying freaks' at liberal media: I'm 'doing God's work'
- Houston mayor: Sorry that police put man's blind dog on road to die
- HUSAIN: Worlds grand ayatollahs rally behind Sistani
Top 10 U.S. military helicopters
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors